Alamycin LA (Canada)

(Oxytetracycline dihydrate)

Sterile Injectable Solution

A long acting broad-spectrum antibiotic.

DIN 00670804

Veterinary Use Only

Patent number: CA2194576

Description

ALAMYCIN LA Injectable Solution is specially formulated to provide sustained antibiotic blood levels up to 4 days in cattle and pigs following a single treatment.

ALAMYCIN LA is a sterile, long acting stable aqueous solution containing oxytetracycline dihydrate equivalent to 200 mg oxytetracycline base per mL.

ADVANTAGES:

ALAMYCIN LA Injectable Solution offers the advantage of combining broad-spectrum effectiveness against both Gram-positive and Gram-negative bacteria, with prolonged antibiotic blood levels up to 4 days duration following a single treatment. ALAMYCIN LA yields higher blood levels during the first 24 hours and comparable levels up to 48 hours when compared to daily injections of oxytetracycline 100 mg/mL (ALAMYCIN LP).

Alamycin LA Indications

ALAMYCIN LA Injectable Solution is indicated in the treatment of infections caused by oxytetracycline susceptible bacteria in cattle and swine.

Cattle: Bacterial Pneumonia, Pasteurellosis (associated with shipping fever complex), Mastitis, Metritis, Calf Scours (Bacterial Enteritis), Foot Rot, Navel ill, Calf Diphtheria, Leptospirosis, Blackleg/Malignant Edema, Peritonitis, Joint ill.

Swine: Erysipelas, Bacterial Enteritis, Leptospirosis, Metritis, Mastitis, Bacterial Pneumonia.

Dosage and Administration

For administration by intramuscular injection to cattle and swine and subcutaneous injection to cattle only.

Cattle: administer by deep intramuscular injection or subcutaneous injection at a single dose rate of 1 mL per 10 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).

Swine: administer by deep intramuscular injection at a single dose rate of 1 mL per 10 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).

It is recommended that the maximum dose at any one site is 10 mL in cattle and 5 mL in pigs to minimize local tissue irritation at the injection site. Intramuscular injections should be made deep into the fleshy part of the muscle such as the neck. Subcutaneous injections should be administered in the neck region.

Following administration, temporary localized swelling may be observed at the site of injection for several days. This is due to the high concentration and long acting effect of the product.

ALAMYCIN LA Injectable Solution should be warmed to body temperature prior to administration.

If clinical improvement is not observed after 48 hours, clinical re-evaluation may be required. In non-responsive cases, consideration may be given to the use of an alternative antibiotic.

NOTE:

Treatment with ALAMYCIN LA Injectable Solution only, in severe diseases cases, may be insufficient.

Warning

Intramuscular administration

Treated cattle and swine must not be slaughtered for use in food for at least 21 days after the latest treatment with this drug.

Subcutaneous administration

Treated cattle must not be slaughtered for use in food for at least 42 days after the latest treatment with this drug.

Do not use in lactating dairy cattle.

NOTE:

To avoid the possibility of excessive trim at the site of injection, do not slaughter cattle for at least 42 days after the latest treatment with this drug.

Alamycin LA Caution

Occasional hypersensitivity reactions (anaphylaxis) have been observed following the parenteral administration of oxytetracycline. If such side effects occur, discontinue use of the drug and administer epinephrine immediately.

The safety of this product in pregnant animals has not been demonstrated.

Storage

Store below 25°C and protect from light. Do not freeze.

PRESENTATION:

ALAMYCIN LA Injectable Solution is available in multidose 250 mL and 500 mL vials.

Manufactured by: Norbrook Laboratories Limited, Newry, Co. Down, BT35 6JP, Northern Ireland

Distributed by: Vetoquinol N.-A. Inc., 2000 chemin Georges, Lavaltrie, Quebec, Canada, J5T 3S5

001492I05

CPN: 1234270.2